The effectiveness of Epidiolex for the treatment of certain kinds of epilepsy in both children and adults is dose-dependent, according to a recent report in MD Magazine.
“There was a linear relationship between the cannibidol dose and the plasma levels of the drug, and higher plasma levels were associated with a higher chance for improvement of the seizure rate,” Jerzy Szaflarski, MD, PhD, Director of the Division of Epilepsy in the Department of Neurology at the University of Alabama (UAB), Birmingham, explained to MD Magazine®.
The encouraging news was presented as a late-breaking poster at the 2018 annual meeting of the American Epilepsy Society (AES) held in New Orleans. The poster was presented by Kathleen Hernando, MPH, who coordinates projects in the UAB Epilepsy Center. The research was headed by Jerzy Szaflarski, MD, PhD.